|
STRN4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.390000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.774200E-01 |
| Normal-vs-Stage2 |
5.380400E-01 |
| Normal-vs-Stage3 |
2.225000E-01 |
| Normal-vs-Stage4 |
8.642600E-01 |
| Stage1-vs-Stage2 |
3.841000E-01 |
| Stage1-vs-Stage3 |
3.260400E-01 |
| Stage1-vs-Stage4 |
9.544600E-01 |
| Stage2-vs-Stage3 |
1.412820E-01 |
| Stage2-vs-Stage4 |
5.822600E-01 |
| Stage3-vs-Stage4 |
5.656000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.497200E-01 |
| Normal-vs-AfricanAmerican |
5.014000E-01 |
| Normal-vs-Asian |
5.665400E-01 |
| Caucasian-vs-AfricanAmerican |
7.323400E-01 |
| Caucasian-vs-Asian |
7.827200E-01 |
| AfricanAmerican-vs-Asian |
8.663400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.198000E-01 |
| Normal-vs-Female |
1.736570E-01 |
| Male-vs-Female |
2.687000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.709000E-01 |
| Normal-vs-Extreme_Weight |
8.444400E-01 |
| Normal-vs-Obese |
2.206600E-01 |
| Normal-vs-Extreme_Obese |
9.522000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.452400E-01 |
| Normal_Weight-vs-Obese |
1.714980E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.074000E-01 |
| Extreme_Weight-vs-Obese |
2.860600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.860000E-01 |
| Obese-vs-Extreme_Obese |
4.979000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.503680E-02 |
| Normal-vs-Age(41-60Yrs) |
7.414100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.294200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.486300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.521500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.041170E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.516840E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.023700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.377680E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.213650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.188000E-02 |
| Normal-VS-Type2 PRCC |
9.683400E-03 |
| Normal-VS-KIRP CIMP |
5.349600E-02 |
| Normal-VS-Unclassified PRCC |
4.208600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.52269999942334E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.555210E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.087400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.98940000000403E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.356330E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.035180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.461000E-01 |
| Normal-vs-N1 |
6.616100E-02 |
| Normal-vs-N2 |
7.722000E-01 |
| N0-vs-N1 |
1.163790E-02 |
| N0-vs-N2 |
4.605600E-01 |
| N1-vs-N2 |
5.270800E-01 |
|
|
